CAM Guidance Statement On Probiotics Is “Astonishing,” Concerns Experts

FDA's Center for Biologics Evaluation and Research may be laying the groundwork for greater control of the regulation of probiotics in the agency's recently released guidance document on "complementary and alternative medicine products," according to industry stakeholders

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Archive

More from Pink Sheet